Compounds

Compound library

Every compound we cover: what it is, where the research stands, and every vendor report we’ve published for it. Factual reference only; never dosing or treatment guidance.

Request a compound

35 compounds

The compounds described in this library are research-use-labeled chemicals and are not FDA-approved for human use. This content is factual scientific reference drawn from published literature. It is not medical, dosing, or purchasing advice. VialReport does not sell, supply, or distribute any compound.

Retatrutide

Not yet tested

LY3437943

Phase 3 clinical (investigational) Not approved · investigational

An investigational triple hormone receptor agonist developed by Eli Lilly, activating the GIP, GLP-1, and glucagon receptors. It is in Phase 3…

Selank

Not yet tested

TP-7, tuftsin analogue

Early clinical Not FDA-approved · registered in Russia

A synthetic heptapeptide derived from the immune peptide tuftsin, developed in Russia and registered there for anxiety-related indications. Not FDA-approved, with the…

Neurological and Cognitive Research Request a test →

Semaglutide

Not yet tested

Ozempic, Wegovy, Rybelsus (brands)

Established human clinical FDA-approved (brand products)

A GLP-1 receptor agonist developed by Novo Nordisk and approved by the FDA under several brand names for type 2 diabetes and…

GLP-1 and Metabolic Request a test →

Semax

Not yet tested

Met-Glu-His-Phe-Pro-Gly-Pro, ACTH(4-7) analogue

Early clinical Not FDA-approved · registered in Russia

A synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone, developed in Russia and registered there as a medicine. Not FDA-approved, and…

Neurological and Cognitive Research Request a test →

Sermorelin

Not yet tested

Sermorelin acetate, GRF 1-29, Geref (discontinued brand)

Established human clinical Formerly FDA-approved · brand discontinued

A synthetic peptide comprising the first 29 amino acids of growth hormone-releasing hormone. It was previously FDA-approved as a prescription medicine and…

Growth Hormone Secretagogues Request a test →

SS-31

Not yet tested

Elamipretide, Forzinity (brand), MTP-131, Bendavia

Established human clinical FDA accelerated approval 2025 (Barth syndrome only)

A mitochondria-targeted tetrapeptide that received FDA accelerated approval in 2025 under the brand name Forzinity as the first approved treatment for Barth…

Aging and Mitochondrial Biology Request a test →

TB-500

Not yet tested

TB500, Ac-LKKTETQ (thymosin beta-4 fragment 17-23)

No human data Not FDA-approved · PCAC review July 2026

A short synthetic peptide corresponding to a fragment of thymosin beta-4, a much larger naturally occurring protein. It is not the same…

Tissue Repair and Regeneration Request a test →

Tesamorelin

Not yet tested

Egrifta (brand), TH9507

Established human clinical FDA-approved (brand product)

A synthetic GHRH analogue approved by the FDA under the brand name Egrifta for reduction of excess visceral abdominal fat in patients…

Growth Hormone Secretagogues Request a test →

Thymosin Alpha-1

Not yet tested

Tα1, Thymalfasin, Zadaxin (brand)

Established human clinical Not FDA-approved · approved in other countries

A 28-amino-acid immune-modulating peptide derived from thymosin fraction 5. It is approved as a medicine in a number of countries outside the…

Other Request a test →

Thymosin Beta-4

Not yet tested

Tβ4, TB4, TMSB4X gene product

Early clinical Not FDA-approved

A naturally occurring 43-amino-acid peptide expressed in most cell types, and a major intracellular G-actin-sequestering peptide. It is the full-length parent molecule…

Tissue Repair and Regeneration Request a test →

Tirzepatide

Not yet tested

Mounjaro, Zepbound (brands)

Established human clinical FDA-approved (brand products)

A dual GIP and GLP-1 receptor agonist developed by Eli Lilly and approved by the FDA under brand names for type 2…

GLP-1 and Metabolic Request a test →

Stay current

Get notified when new reports publish.

Free. We email when results are in, and nothing else.